Our Mission - Committed to the User Experience
Enable Injections develops and manufactures devices that allow patient self-administration of high volume/viscosity drugs. The Enable Injector technology is a discrete body-worn device that provides a comfortable injection experience allowing the patient to continue with normal daily activities. The Enable system is designed to utilize any standard container closure system, including a syringe, vial or cartridge.
Our History
Enable Injections was founded in February 2010 in Cincinnati, Ohio by an experienced team of executives and Board Members. The CEO, Michael Hooven, has worked with the Board Members for an average of over 20 years, and this team has started three highly successful medical device companies, including Enable Medical Corporation, AtriCure (ATRC), and Enable Injections.
Enable Medical Corporation was founded in 1994, and returned over 33x to initial investors upon its acquisition in 2005. AtriCure (ATRC) was founded in 2000 and completed an IPO in August 2005. AtriCure is currently the leading company in the world in the surgical treatment of Atrial Fibrillation, and has a market capitalization of over $500MM.
The Enable Injections design team consists of some of the top medical device design engineers in the world. Two of our engineers have over 100 issued and pending US patents in a wide variety of medical devices. Our lead design engineer was awarded the Johnson and Johnson Chairman’s Medal. Our development members have had direct responsibility for developing and introducing over 200 medical devices to the marketplace, representing over $10BB in sales. Our Human Factors group has conducted one of the most comprehensive programs in the industry to develop the Enable Injector. Our Operations and Project Management team has direct experience in the development and market introduction of some of the most recent and innovative products on the market today.
